Assessing Immunovant (IMVT) Valuation After Strong IMVT-1402 Data And Refocused Pipeline Strategy Simply Wall St 5d
Roivant Sciences Shares Jump 14.43% to $32.28 on Strong IMVT-1402 Rheumatoid Arthritis Data International Business Times - AU Edition 6d
Immunovant Shares Surge 31.86% to $34.67 on Positive IMVT-1402 Rheumatoid Arthritis Data International Business Times - AU Edition 6d
Scientists discover a surprising cause of rheumatoid arthritis Knowridge Science Report 2d Science Global Health All sources
Immunovant shares surge 31.86% to $34.67 on positive IMVT-1402 rheumatoid arthritis data International Business Times - AU Edition 6d IMVT-1402 All sources
Horizon scanning: therapeutic targets for chronic pain in inflammatory arthritis Hospital Pharmacy Europe 5d Psychology Science Global Health
Post-Covid hip damage driving surge in joint replacements among young Indians The Times of India 1d Post-Covid India
